Does the CLNN filing show total aggregated proceeds or a cumulative share total?

The excerpt provides per-transaction share counts and cash amounts only. The filing lists individual trade lines; it does not present a single aggregated proceeds total in the provided content.

Symbiosis II reports multiple common-share sales

Q: How many shares did Symbiosis II LLC sell on 03/31/2026 in the CLNN filing?

Symbiosis II LLC sold 31,297 shares on 03/31/2026. The transaction is reported with a cash value of $152,316.52 in the filing's line-item for that date.

Q: Who is the reporting party in the CLNN Form 144 entries?

The transactions are reported for Symbiosis II LLC. The filing includes Symbiosis II LLC's address and multiple dated common-share dispositions attributed to that entity.

CLNN reports multiple proposed and executed sales of Common Stock by Symbiosis II LLC as disclosed on Form 144.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

144

Rhea-AI Filing Summary

CLNN reports multiple proposed and executed sales of Common Stock by Symbiosis II LLC as disclosed on Form 144. The filing lists numerous open-market dispositions on dated entries, including 31,297 shares on 03/31/2026 for $152,316.52 and 32,705 shares on 01/12/2026 for $179,867.17. Transactions are shown across January–March 2026 with individual trade sizes and cash amounts reported per line item.

Key Figures

Trade example: 31,297 shares Proceeds example: $152,316.52 Trade example: 32,705 shares +2 more

5 metrics

Trade example 31,297 shares 03/31/2026 transaction

Proceeds example $152,316.52 cash amount for 03/31/2026 trade

Trade example 32,705 shares 01/12/2026 transaction

Proceeds example $179,867.17 cash amount for 01/12/2026 trade

Single-line entry 125,706 listed near 'Securities To Be Sold' (06/20/2023 line item)

Key Terms

Form 144, Open Market Purchase, Issuer, Common

4 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Open Market Purchase market

"Open Market Purchase | Issuer | 125706 | 06/20/2023"

An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.

Issuer regulatory

"Open Market Purchase | Issuer | 125706"

Common financial

"Common | Symbiosis II LLC ... | Common | 03/31/2026 | 31297"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 for CLNN show?

It lists proposed and completed sales of Common Stock by Symbiosis II LLC. The filing details multiple open-market dispositions on specific dates with per-trade share counts and cash amounts, spanning January through March 2026.

How many shares did Symbiosis II LLC sell on 03/31/2026 in the CLNN filing?

Symbiosis II LLC sold 31,297 shares on 03/31/2026. The transaction is reported with a cash value of $152,316.52 in the filing's line-item for that date.

Are the CLNN sales shown as open-market transactions?

Yes — the filing lists open-market purchases/sales for the securities shown. Individual lines identify trades marked as open-market entries with dates and cash proceeds for each disposition.

Who is the reporting party in the CLNN Form 144 entries?

The transactions are reported for Symbiosis II LLC. The filing includes Symbiosis II LLC's address and multiple dated common-share dispositions attributed to that entity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/31/2026 - 05:05 PM

144: Filer Information

Filer CIK

0002006045

Filer CCC

XXXXXXXX

Is this a LIVE or TEST Filing?

LIVE TEST

Submission Contact Information

Name

Phone

E-Mail Address

144: Issuer Information

Name of Issuer

Clene Inc

SEC File Number

001-39834

Address of Issuer

6550 SOUTH MILLROCK DRIVE
SUITE G50
SALT LAKE CITY
UTAH
84121

Phone

8016769695

Name of Person for Whose Account the Securities are To Be Sold

Symbiosis II LLC

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Former Board Member

144: Securities Information

Title of the Class of Securities To Be Sold

Name and Address of the Broker

Number of Shares or Other Units To Be Sold

Aggregate Market Value

Number of Shares or Other Units Outstanding

Approximate Date of Sale

Name the Securities Exchange

Common

Merrill Lynch
555 California St
Ste 1800
San Francisco CA 94104

30518

149233.02

11778307

03/24/2026

Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class

Date you Acquired

Nature of Acquisition Transaction

Name of Person from Whom Acquired

Is this a Gift?

Date Donor Acquired

Amount of Securities Acquired

Date of Payment

Nature of Payment *

Common

06/20/2023

Open Market Purchase

Issuer

125706

06/20/2023

Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller

Title of Securities Sold

Date of Sale

Amount of Securities Sold

Gross Proceeds